In addition, using both pharmacological inhibition and genetic KO, we found that the cellular entry and transendothelial BBB transport of P-selectin-targeted materials to SHH-MB tumour tissue is Cav1 dependent and is not likely to occur by passive passage through interendothelial spaces, as suggested by recent studies15. This evidence concerns the gene CAV1 and neoplasm.